C. Ola Landgren: Thrilled to welcome Brian Walker to the Sylvester Myeloma Institute
Ola Landgren, Professor of Medicine, Chief of the Division of Myeloma at University of Miami and Leader of Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center, shared a post on LinkedIn:
“We’re thrilled to welcome Professor Brian Walker to the Sylvester Myeloma Institute at the Sylvester Comprehensive Cancer Center, University of Miami! His expertise will be a huge asset to our mission of advancing myeloma research and treatment. Welcome to the team, Dr. Walker!
Dr. Walker will be using patient-derived xenografts to model how different myeloma subgroups respond to new treatments – helping to shape the future of precision medicine!
Epigenetics and Myeloma: His research shows that DNA methylation and histone modifications play a key role in prognosis and gene regulation, evolving throughout disease progression.
Single-Cell Analysis: Myeloma is complex, and we’re leveraging cutting-edge single-cell tech to uncover how genomic heterogeneity drives tumor evolution and treatment response.
Follow us for more updates on our mission to advance myeloma research in beautiful Miami!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023